[Vascular endothelial growth factor and the effects of endostatin on the inhibition of tumor angiogenesis in treating hepatocarcinomas].
Deng
Jing-Yu
JY
Department of General Surgery, West China Hospital of Sichuan University, Chengdu 610041, China. dengery@sohu.com
He
Sheng
S
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000628:therapy; D043169:Endostatins / Q000627:therapeutic use*; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D009389:Neovascularization, Pathologic; D042461:Vascular Endothelial Growth Factor A / Q000627:therapeutic use*
D020533:Angiogenesis Inhibitors; D043169:Endostatins; D042461:Vascular Endothelial Growth Factor A